Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

First-In-Human (FIH), Single Ascending Dose (SAD) Study of FluoroEthylNorMemantine (FENM)

ReST Therapeutics · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
alzheimer-diseasealzheimer-s-diseasemajor-depressive-disorderptsd
ptsd, alzheimer disease, brain diseases, neuro-degenerative disease, major depressive disorder, treatment resistant depression, nmda, alzheimer's disease, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 916380
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.